Log in

Relevant bibliographies by topics / Implantable cardioverter-defibrillators

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers

Academic literature on the topic 'Implantable cardioverter-defibrillators'

Author: Grafiati

Published: 4 June 2021

Last updated: 20 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Implantable cardioverter-defibrillators.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Implantable cardioverter-defibrillators"

1

Connelly, Derek T. "Implantable cardioverter-defibrillators." Heart 86, no. 2 (August 1, 2001): 221–26. http://dx.doi.org/10.1136/hrt.86.2.221.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

DiMarco, John P. "Implantable Cardioverter–Defibrillators." New England Journal of Medicine 349, no. 19 (November 6, 2003): 1836–47. http://dx.doi.org/10.1056/nejmra035432.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Harris, Stuart, and Mehul Dhinoja. "Implantable cardioverter defibrillators." Clinical Medicine 7, no. 4 (August 1, 2007): 397–400. http://dx.doi.org/10.7861/clinmedicine.7-4-397.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Ng, G. A., A. P. Rae, A. C. Rankin, and S. M. Cobbe. "Implantable Cardioverter- Defibrillators." Scottish Medical Journal 41, no. 2 (April 1996): 35–37. http://dx.doi.org/10.1177/003693309604100201.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Fazio, Gregory P., and Enrico P. Veltri. "Implantable cardioverter-defibrillators." Current Opinion in Cardiology 6, no. 1 (February 1991): 72–78. http://dx.doi.org/10.1097/00001573-199102000-00011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Frank, Gunter, and Doris Lowes. "Implantable cardioverter-defibrillators." Coronary Artery Disease 3, no. 3 (March 1992): 210–18. http://dx.doi.org/10.1097/00019501-199203000-00007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Ballantyne, Helen. "Implantable cardioverter defibrillators." Nursing Standard 31, no. 49 (August 2, 2017): 64–65. http://dx.doi.org/10.7748/ns.31.49.64.s48.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Mark Estes, N. A., Antonis S. Manolis, and Paul J. Wang. "Implantable Cardioverter-Defibrillators." Journal of Clinical Engineering 20, no. 3 (May 1995): 205–10. http://dx.doi.org/10.1097/00004669-199505000-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Aronow, Wilbert S. "Implantable Cardioverter-Defibrillators." American Journal of Therapeutics 17, no. 6 (November 2010): e208-e220. http://dx.doi.org/10.1097/mjt.0b013e3181bdc65d.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Shah, Chetan P., R. K. Thakur, Baiyan Xie, and Vrijendra K. Hoon. "IMPLANTABLE CARDIOVERTER DEFIBRILLATORS." Emergency Medicine Clinics of North America 16, no. 2 (May 1998): 463–89. http://dx.doi.org/10.1016/s0733-8627(05)70011-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Implantable cardioverter-defibrillators"

1

Myers, Gina. "The impact of participation in a support group on perception of social support and level of anxiety in patients with an implantable cardioverter defibrillator." Diss., Online access via UMI:, 2005. http://wwwlib.umi.com/dissertations/fullcit/3165054.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Reid, Suzanne Shirley. "Friend or intruder? : Living with an implantable defibrillator : patients' and partners' experiences /." Electronic version, 2001. http://adt.lib.uts.edu.au/public/adt-NTSM20041104.172632/index.html.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Sadarmin, Praveen P. "Cardiologists' knowledge, attitudes and application of risk towards implantable cardioverter defibrillators." Thesis, University of Leicester, 2016. http://hdl.handle.net/2381/37600.

Full text

Abstract:

Patients with impaired left ventricular systolic function have an increased risk of sudden cardiac death. The implantable cardioverter defibrillator (ICD) is an effective therapy to treat life-threatening arrhythmias and randomized controlled trials have demonstrated statistically significant reductions in all-cause mortality in select patient groups. Despite this wealth of published data, the uptake of ICDs in high risk population remains low and the exact reasons not known. My study focuses on the evidence for ICD therapy from the landmark RCTs that have influenced the current guidelines. Most trials have only published relative risk reduction or hazard ratios. The first part of this thesis analyzes data to reveal absolute risk reduction, the number needed to treat and the findings standardized for length of follow-up. There is considerable variation in the magnitude of benefit between different heart failure aetiologies and other patient characteristics highlighting the difficulty in generalising the results. UK cardiologists’ knowledge of guidelines, estimates of 3-year mortality, management decisions, factors that influence decisions, influence of age, device cost, and overall attitudes to ICDs as a form of therapy was assessed with a questionnaire. There was lack of awareness of UK ICD guidelines amongst non-implanting cardiologists and even when guidelines were known they were often not applied, particularly in primary prevention setting. Most cardiologists are not aware of the magnitude of benefit an ICD offers and overestimate the effect in secondary prevention. In addition, there is also bias against elderly patients. The final part of my thesis focuses on exploring barriers to primary prevention ICD uptake. The aim was to see what action was taken when all the data required for making a referral or assessment was available. Our study suggests more than half of potentially eligible patients do not receive ICD therapy. A low referral rate, lack of screening programmes and age bias seem to be the stumbling blocks for primary prevention ICD in the UK.

APA, Harvard, Vancouver, ISO, and other styles

4

Hopgood, Daniel A. L. "Quality of Life in Adolescents and Young Adults with Implantable Cardioverter-Defibrillators." University of Cincinnati / OhioLINK, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=ucin150479872457424.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Crawford, Rebecca Susan. "Health Beliefs Related to Physical Activity in Patients with Implantable Cardioverter Defibrillators." Diss., The University of Arizona, 2013. http://hdl.handle.net/10150/311469.

Full text

Abstract:

Low levels of physical activity (PA) are a significant predictor of early death among recipients of implantable cardioverter defibrillators (ICDs). Regular, moderate PA is associated with improved quality of life (QOL), reduced arrhythmia burden, and improved health outcomes in ICD recipients yet many do not engage in PA and the reasons for lack of engagement are unclear. The purpose of this descriptive, cross-sectional study was to examine health beliefs related to PA and QOL in adults living with ICDs. The Health Belief Model provided the theoretical framework for this study. A convenience sample of 107 adult, ICD recipients (26 females and 81 males) were recruited from five cardiology clinic settings within the same private practice. Seventy-seven percent completed the study tasks (N=81). Subjects completed a Demographic Data Questionnaire, Self-Efficacy Expectations after ICD Scale, Exercise Self-Efficacy Scale, Health Belief Questionnaire, Incidental and Planned Exercise Questionnaire and Quality of Life Medical Outcomes Survey-SF36®. Clinical data was collected from the medical record. Mean age of the subjects was 70.23 yrs. ± 11.76 yrs. The majority were male (71.6 percent) and 77.8 percent were White, non-Hispanic. Most were insured by Medicare (79 percent), were retired (50 percent) and reported incomes less than 20,000 dollars/year (39 percent). Over 98 percent were diagnosed with heart failure and almost 40 percent reported their physical activity had decreased since having an ICD implanted. There were no differences in health beliefs and QOL scores between subjects who had an ICD as a primary or secondary prevention of sudden cardiac death. Predictors of PA participation in this population were Self-Efficacy for Exercise (SEE) beliefs, Self-Efficacy ICD (SEICD) beliefs, age and NYHA Class. Almost 33 percent of variance in PA participation can be explained by SEE (b = 2.407, β = .390, t = 3.911, p<.01); SEICD (b =2.304, β = .215, t = 2.149, p<.05); age (b = -.394, β = -.234, t =-2.277, p<.05); and NYHA Class (b = -6.373, β =-.198, t = -1.998, p =<.05). Findings indicate the strength of self-confidence in influencing healthy behavior. Findings support the need for more research in identifying barriers and predictors of PA participation in adult, ICD recipients.

APA, Harvard, Vancouver, ISO, and other styles

6

Humphreys, Nina Kumari. "Living with an ICD : developing a brief psychological intervention for patients living with an implantable cardioverter defibrillator." Thesis, Swansea University, 2014. https://cronfa.swan.ac.uk/Record/cronfa43026.

Full text

Abstract:

The implantable cardioverter defibrillator (ICD) is a small medical device, implanted underneath the collarbone with wires leading from it to the heart. The device detects and terminates ventricular arrhythmias by delivering an electric shock, that otherwise would most likely lead to sudden cardiac arrest and sudden cardiac death. The ICD is perceived as the 'gold standard' treatment therapy for patients at risk of sudden cardiac death resulting from fast electrical rhythms (Bleasdale, Ruskin, O'Callaghan, 2005). However, ICD recipients have reported high levels of psychological distress such as anxiety and depression and a reduced quality of life (e.g. clinical review by Sears, Matchett & Conti, 2009). This thesis describes the development of a brief psychological intervention for patients living with an ICD based on the Medical Research Council's (2008) guidelines. The first stage in the development of the intervention was a qualitative study. Thirtysix ICD participants (ICD patients and partner) were recruited in south Wales. Semistructured interviews were conducted with each participant separately. Thirteen of the patients had not experienced an ICD shock. Transcripts were analysed by thematic analysis (Braun and Clarke, 2006) using a cognitive-emotional-coping framework. General findings revealed patients did not know how to regain normality after their ICD and highlighted common worries were identified. Accordingly, the intervention aimed to be a structured guide underpinned by cognitive behavioural theory. It aimed to address common worries and bridge the gap between hospital discharge and patient's 6-week follow up appointment. The intervention was tested using a pilot randomised control trial. Ninety-nine participants were randomised to an intervention or control group. Differences between groups at baseline were adjusted by analysis of covariance (ANCOVA) to control for differences at 3- and 6-months. Results revealed the intervention group reported improved levels of depression, increased levels of mild exercise and increased patient acceptance to the ICD compared to the control group at 6-months. The simplicity and cost-effectiveness of this intervention suggests that not only is it theory and evidenced based, but should be sustainable long term. The next stage would be to carry out a fully powered randomised control trial.

APA, Harvard, Vancouver, ISO, and other styles

7

Velavan, Periaswamy. "Risk stratification in patients with heart failure and in patients with implantable cardioverter-defibrillators." Thesis, University of Hull, 2011. http://hydra.hull.ac.uk/resources/hull:5294.

Full text

Abstract:

Heart failure is a very common medical condition with significant mortality and morbidity. Patients hospitalised with heart failure are at high risk of death in the short term and patients with chronic heart failure in the community are also at a high risk of death in the medium to long term. It is difficult to accurately identify those at a higher risk of death as current methods of risk stratification lack both sensitivity and specificity. The available treatments for prevention of sudden death in patients with heart failure such as Implantable Cardioverter Defibrillators (ICD) are expensive and do not abolish the risk of sudden death completely. Hence it is necessary to improve risk stratification methods in patients with heart failure and identify factors predicting mortality in those patients with ICD protection. This thesis first describes a series of studies examining the clinical factors that predict increased risk of short-term mortality in patients with a recent hospitalisation for heart failure. These include examination of patient demographics, clinical history and examination, blood tests, electro-cardiographic and echo-cardiographic variables and medication. Based on these variables, I have formulated a simple scoring system to predict short term mortality in hospitalised patients with heart failure. This score was validated in a prospective study of contemporary heart failure population with a recent hospital admission. The relationship of cholesterol and risk of death in heart failure was examined in detail. Then, the utility of Holter monitoring and signal averaged electro cardiograms (SAECG) for risk stratification were examined based on the prognostic value of abnormalities found by these tests in patients with chronic heart failure. Finally patients with heart failure deemed at high risk of sudden death and had ICDs implanted were studied and factors predicting shocks and mortality were identified. Two separate studies were done, first in population who had ICDs mainly for secondary prevention and the second in patient population who had ICDs exclusively for primary prevention. From these studies, I have identified those clinical characteristics that are associated with high risk of death in patients with acute and chronic heart failure and those associated with death in patients with heart failure after ICD implantation.

APA, Harvard, Vancouver, ISO, and other styles

8

Wilson, David G. "Subcutaneous and transvenous implantable cardioverter defibrillators : developing an individualised approach to assessment and treatment." Thesis, University of Southampton, 2017. https://eprints.soton.ac.uk/415534/.

Full text

Abstract:

In recent years the subcutaneous implantable cardioverter-defibrillator (S-ICD) has emerged as a novel technology which offers an alternative choice to the traditional transvenous implantable cardioverter-defibrillator (TV-ICD) in treatment and prevention of sudden cardiac death. Early experience with the S-ICD however has highlighted that its capacity to accurately sense the cardiac signal can be challenged, in particular with regard to the risk of varying amplitude of signals and risk of T wave oversensing. S-ICD sensing is therefore an important weakness of this technology which this thesis addresses. Initially only a relatively small group of patients were thought to be suitable for S-ICD, in particular patients with difficult venous anatomy or young patients. Therefore I explored how the important ECG parameters in S-ICD sensing, the R wave, the T wave and the R:T ratio, vary when measured from a right compared to a left parasternal lead position in a population of patients with complex congenital heart disease and normal controls. I go on to explore how the R wave, T wave and R:T ratio in the same patient population vary with posture and discuss how this relates to potentially clinically important in relation to S-ICD sensing. As the sensed S-ICD signal resembles the signal measured with a standard 12 lead ECG, I go on to evaluate what are the ECG predictors of T-wave oversensing are. Lastly, I explore how application of mathematical vector transformation techniques can help reconstruct an 8 lead ECG from 2 S-ICD vectors, and from then create a 12-lead ECG, and I discuss how this technique may potentially help solve some sensing problems related to the S-ICD. Within this thesis, I demonstrate that much could be done at an individual level (optimise lead position, identify patients at risk of T wave oversensing and using vector transformation to reduce the likelihood of inappropriate therapy) in order to maximise the potential benefit (and reduce the unwanted consequences) of S-ICDs. This thesis has advanced the understanding of how to improve therapy to treat SCD by reducing the unwanted events of S-ICD therapy by developing a concept of a tailored assessment of patient’s suitability for ICD therapy.

APA, Harvard, Vancouver, ISO, and other styles

9

Byrd, Israel A. "Interactions between trains of premature stimuli and anatomically anchored reentrant wavefronts implications for antitachycardia pacing /." Birmingham, Ala. : University of Alabama at Birmingham, 2006. http://www.mhsl.uab.edu/dt/2006p/byrd.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Jama, Zimasa Vuyo. "Performance of re-used pacemakers and implantable cardioverter defibrillators compared with new devices at Groote Schuur Hospital, Cape Town, South Africa." Master's thesis, University of Cape Town, 2016. http://hdl.handle.net/11427/20958.

Full text

Abstract:

Objectives: Little is known about the performance of re - used pacemakers and implantable cardioverter defibrillators (ICDs) in Africa. We sought to compare the risk of infection and the rate of malfunction of re - used pacemakers and ICDs with new devices at Groote Schuur Hospital in Cape Town, South Africa. Methods: This was a retrospective case comparison study of performance of re - used pacemakers and ICDs in comparison with new devices at Groote Schuur hospital over a 10 year period. The outcomes were incidence of device infection, device malfunction, early battery depletion, and device removal due to infection, malfunction, or early battery depletion. Results: Data for 126 devices implanted in 126 patients between 2003 and 2013 were analysed, of which 102 (81%) were pacemakers (51 re - used and 51 new) and 24 (19%) were ICDs (12 re - used and 12 new). There was no device infection, malfunction, early battery depletion or device removal in either the re - used or new pacemaker groups ov er the median follow up of 15.1 months (interquartile range (IQR), 1.3 - 36.24 months) for re - used pacemakers and 55.8 months (IQR, 20.3 - 77.8 months) for new pacemakers. In the ICD group, no device infection occurred over a median follow up of 35.9 months (I QR, 17.0 - 70.9 months) for re - used ICDs and 45.7 months (IQR, 37.6 - 53.7 months) for new ICDs. One device delivered inappropriate shocks which resolved without intervention and no harm to the patient, this re - used ICD subsequently needed generator replacement 14 months later. In both, the pacemaker and ICD groups, there were no procedure non related infections documented for the respective follow up periods. Conclusion: No significant differences were found in performance between re - used and new pacemakers and ICDs with respect to infection rates, device malfunction, and battery life and device removal for complications. Pacemaker and ICD reusee is feasible and safe and is a viable option for patients with bradyarrhythmias and tachyarrthythmias.

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Implantable cardioverter-defibrillators"

1

Jackson, Morgan N. Implantable automatic cardioverter-defibrillators. Rockville, MD: U.S. Dept. of Health and Human Services, Public Health Service, National Center for Health Services Research and Health Care Technology Assessment, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

The implantable defibrillator: From concept to clinical reality. Basel: Karger, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Serge, Barold S., Sinnaeve Alfons F, and Barold S. Serge, eds. Implantable cardioverter-defibrillators step by step: An illustrated guide. Chichester, West Sussex, UK: Wiley-Blackwell, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Parkes, Julie. Implantable cardioverter defibrillators: Arrhythmias : a rapid and systematic review. Alton: Core Research on behalf of the NCCHTA, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Fromer, Martin. Clinical aspects of implantable cardioverter-defibrillator therapy. Armonk, NY: Futura Pub. Co., 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

W, Kroll Mark, and Lehmann Michael H, eds. Implantable cardioverter defibrillator therapy: The engineering-clinical interface. Norwell, Mass., USA: Kluwer Academic Publishers, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Implantable cardioverter-defibrillator: A practical manual. Dordrecht: Kluwer Academic, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Liem, L. Bing. Implantable cardioverter-defibrillator: A practical manual. Dordrecht: Kluwer Academic, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Riccardo, Cappato, and Siebels Jürgen, eds. ICD therapy. Armonk, NY: Futura Pub. Co., 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

1954-, Kenny Tom, ed. The nuts and bolts of ICD therapy. Malden, Mass: Blackwell Futura, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Implantable cardioverter-defibrillators"

1

Khanna, Vinod Kumar. "Implantable Cardioverter Defibrillators." In Implantable Medical Electronics, 293–307. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-25448-7_15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Lampert, Rachel, and Zachary Goldberger. "Implantable Cardioverter-Defibrillators." In Device Therapy in Heart Failure, 155–84. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-59745-424-7_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Korpas, David. "Implantable Cardioverter-Defibrillators." In Implantable Cardiac Devices Technology, 77–86. Boston, MA: Springer US, 2013. http://dx.doi.org/10.1007/978-1-4614-6907-0_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Ramsdale, David R., and Archana Rao. "Implantable Cardioverter Defibrillators." In Cardiac Pacing and Device Therapy, 403–39. London: Springer London, 2012. http://dx.doi.org/10.1007/978-1-4471-2939-4_17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Lipka, Leslie J., and James Coromilas. "Implantable Cardioverter-Defibrillators." In Contemporary Concepts in Cardiology, 619–58. Boston, MA: Springer US, 1999. http://dx.doi.org/10.1007/978-1-4615-5007-5_36.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Chapman, P. D. "Implantable Cardioverter-Defibrillators." In Perioperative Management of Pacemaker Patients, 62–69. Berlin, Heidelberg: Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-76531-5_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Rogers, Dominic, and Abdallah Al-Mohammad. "Implantable cardioverter defibrillators." In Practical Interventional Cardiology, 595–607. Third edition. | Boca Raton, FL : CRC Press, [2018]: CRC Press, 2017. http://dx.doi.org/10.1201/9781315113753-43.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Gomez, Camilo A. "Implantable Cardioverter Defibrillators (ICD)." In Cardiology Procedures, 211–17. London: Springer London, 2016. http://dx.doi.org/10.1007/978-1-4471-7290-1_25.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Rivner, Harold, and Camilo A. Gomez. "Implantable Cardioverter Defibrillators (ICD)." In Cardiology Procedures, 207–11. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-95259-4_27.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Watt, Victoria. "Implantable Cardioverter-Defibrillators in Athletes." In IOC Manual of Sports Cardiology, 415–26. Chichester, UK: John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781119046899.ch38.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Implantable cardioverter-defibrillators"

1

Jaffar, Iram, Muhammad Usman, and Alireza Jolfaei. "Security Hardening of Implantable Cardioverter Defibrillators." In 2019 IEEE International Conference on Industrial Technology (ICIT). IEEE, 2019. http://dx.doi.org/10.1109/icit.2019.8755126.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Abbas, Houssam, Kuk Jin Jiang, Zhihao Jiang, and Rahul Mangharam. "Towards Model Checking of Implantable Cardioverter Defibrillators." In HSCC'16: 19th International Conference on Hybrid Systems: Computation and Control. New York, NY, USA: ACM, 2016. http://dx.doi.org/10.1145/2883817.2883841.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Gomadam, P. M., J. R. Brown, E. R. Scott, and C. L. Schmidt. "Predicting charge-times of implantable cardioverter defibrillators." In 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE, 2009. http://dx.doi.org/10.1109/iembs.2009.5332834.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Zhu, Xin, Mahito Noro, and Kaoru Sugi. "Computer simulation of defibrillations using subcutaneous implantable cardioverter-defibrillators." In 2014 IEEE 6th International Conference on Awareness Science and Technology (iCAST). IEEE, 2014. http://dx.doi.org/10.1109/icawst.2014.6981830.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Jiang, Zhihao, Houssam Abbas, Kuk Jin Jang, Marco Beccani, Jackson Liang, Sanjay Dixit, and Rahul Mangharam. "In-silico pre-clinical trials for implantable cardioverter defibrillators." In 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE, 2016. http://dx.doi.org/10.1109/embc.2016.7590667.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Spano, Ivan Luigi, Sara Sulis, Alessandro Serpi, Ignazio Marongiu, Gianluca Gatto, and Vincenzo Nissardi. "An Automatic Sensing Test procedure for Implantable Cardioverter Defibrillators." In 2015 IEEE International Symposium on Medical Measurements and Applications (MeMeA). IEEE, 2015. http://dx.doi.org/10.1109/memea.2015.7145196.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Katrib, Juliano, Pierre Schmitt, Isabelle Magne, Djilali Kourtiche, Martine Souques, and Mustapha Nadi. "Implantable cardioverter-defibrillators exposed to low frequency magnetic fields." In 2011 XXXth URSI General Assembly and Scientific Symposium. IEEE, 2011. http://dx.doi.org/10.1109/ursigass.2011.6051387.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Kilhwan Kim, Unsun Cho, Seunghyun Lim, Youngcheol Chae, Yunho Jung, Gunhee Han, and Jaeseok Kim. "A 1.5V mixed signal biomedical SOC for implantable cardioverter defibrillators." In 2007 IEEE International SOC Conference (SOCC). IEEE, 2007. http://dx.doi.org/10.1109/socc.2007.4545414.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Boyer, Richard B., Pramode Chiruvolu, Arun Jose, Joshua Liu, Adam Sifuentes, Allison Connolly, Britni Crocker, and Peter Stempriewica. "Enhancing SVT Discrimination in Implantable Cardioverter Defibrillators Using MEMS Accelerometers." In ASME 2007 2nd Frontiers in Biomedical Devices Conference. ASMEDC, 2007. http://dx.doi.org/10.1115/biomed2007-38056.

Full text

Abstract:

Sudden cardiac death (SCD) accounts for over 325,000 deaths in the United States per year. Implantable cardioverter defibrillators (ICDs), about 100,000 of which are implanted each year, are used to diagnose and treat cardiac arrhythmias in patients that are at risk for sudden cardiac death due to ventricular fibrillation. Upon detection of an arrhythmia, the ICD has several treatment options, all of which deliver varied amounts of electric current to the myocardium. Detection of ventricular tachycardia (VT) or ventricular fibrillation (VF) prompts the ICD to administer high-energy defibrillation shocks, which can exceed 30J. The current method for sensing arrhythmias is the use of electrodes implanted in the myocardium which are capable of detecting electric potentials. The extensively studied algorithms that analyze electrogram sensor data have allowed ICD’s to achieve a 0% false negative rate for detection of fibrillation. The drawback, however, is the high false positive rate of over 22%. False positives result in inappropriate shocks which have detrimental effects on patient health and quality of life [1].

APA, Harvard, Vancouver, ISO, and other styles

10

Kilhwan Kim, Unsun Cho, Yunho Jung, and Jaeseok Kim. "Design and implementation of biomedical SoC for implantable cardioverter defibrillators." In 2007 IEEE Asian Solid-State Circuits Conference. IEEE, 2007. http://dx.doi.org/10.1109/asscc.2007.4425777.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!